Enovix Corporation (ENVX)

In November 2025, Enovix released its third-quarter financial results, reporting an increase in revenue and non-GAAP gross profit, leading to analysts updating their price targets. In January 2026, the company announced a leadership transition to support manufacturing scale-up. In February 2026, Enovix reported its fourth-quarter and full-year results, achieving revenue growth and improved gross margin. In April 2026, Enovix announced the date for its first-quarter financial results. In May 2026, Steve Bakos was appointed as Senior Vice President of Worldwide Sales, JPMorgan downgraded Enovix's stock rating, and BofA Securities raised its price target for Enovix.

Enovix Corp. experiences demand seasonality, with first-quarter revenue declining due to the seasonal buying cycle of its South Korean defense customers, who typically place orders in the second half of the year. This seasonality was reflected in the company's guidance for Q1 2026 revenue.

Enovix Corporation specializes in the design, development, manufacturing, and commercialization of advanced lithium-ion battery cells, focusing on silicon-anode batteries with a proprietary 3D cell architecture. Their batteries cater to IoT devices, mobile and computing devices, smartphones, smart eyewear, drones, and defense applications, with ongoing development for electric vehicles and energy storage.

Enovix Corp. is headquartered in Fremont, California, and has a global presence with facilities in India, South Korea, and Malaysia. The company generates its maximum revenue from customers in South Korea, followed by Switzerland, the United States, Norway, and Taiwan. In April 2025, Enovix expanded its manufacturing in South Korea by acquiring a battery cell manufacturing facility from SolarEdge.

In October 2025, Enovix was recognized on Fast Company's "Next Big Things in Tech" list for its AI-1™ batteries. However, in May 2026, JPMorgan downgraded its stock due to concerns about the commercialization timeline for smartphone batteries and increasing competition.

Enovix Corp. has a diverse ownership structure, with approximately 50.61% held by institutional shareholders, 19.01% by Enovix insiders, and 30.37% by retail investors. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and Electron Capital Partners, LLC. Significant individual and insider owners include Eclipse GP III LLC, Thurman Rodgers, and Rajendra K. Talluri.